This should go well.
Whether it is safe and effective will be very difficult to gauge without a phase III trial, even in the best of circumstances. When you couple the data to Russia's default tactic of "lie, lie, and lie again", I'm not sure we'll be able to glean anything useful out of it.
It's a stupid worry for a government in this case, because there's no amount of money any company could lose through IP theft that would even be a rounding error compared to how much we would save if a safe and effective vaccine reaches the market. So the balance sheet says that we should be encouraging sharing, not hoarding, and the government should be paying companies to make their research public. The normal rules just don't apply here.
Frankly, there is a bunch of stupid info in this article, such as using HEK293 cells as evidence that there are similarities between the Russian vaccine and the AZ vaccine. HEK293 cells are the most widely used cells in the world for producing viruses, antibodies, and other biologics. I would use the word "ubiquitous" to describe them. I keep 3 variants of them in my lab at all times. I posted not so much for anything other than the headline, which itself is newsworthy. Also, I think the hemming and hawing about IP theft is bullshit. There should be no IP theft even possible, because this research should be public domain. There's a lot better chance of success is 100 companies are working on one promising thing than if each of 100 companies are doing their own, potentially promising thing.